On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Thomas W. Flaig

ResearcherPublications, citations & collaboration network

Thomas W. Flaig is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Thomas W. Flaig have?

ScholarIQindexed works

Thomas W. Flaig has 398 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Thomas W. Flaig have?

ScholarIQcitation count

Thomas W. Flaig has 23,614 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Thomas W. Flaig?

ScholarIQh-index

Thomas W. Flaig has an h-index of 54 in OpenAlex.

What is the i10-index of Thomas W. Flaig?

ScholarIQi10-index

Thomas W. Flaig has an i10-index of 138 in OpenAlex.

What is the ORCID of Thomas W. Flaig?

ScholarIQorcid

The ORCID for Thomas W. Flaig is on the source record.

What is the OpenAlex record for Thomas W. Flaig?

ScholarIQopenalex

The OpenAlex for Thomas W. Flaig is on the source record.

What are the most-cited papers on Thomas W. Flaig?

ScholarIQmost cited works
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher, Karim Fizazi, Fred Saad, Mary‐Ellen Taplin, Cora N. Sternberg, Kurt Miller, Ronald de Wit, Peter F.A. Mulders, Kim N., Neal D. Shore, Andrew J. Armstrong, Thomas W. Flaig, Aude Fléchon, Paul N. Mainwaring, Mark T. Fleming, John D. Hainsworth, Mohammad Hirmand, Bryan Selby, Lynn Seely, Johann S. de Bono
New England Journal of Medicine. 20124,604 CitationsOPEN ACCESS
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. de Bono, Christopher J. Logothetis, Arturo Molina, Karim Fizazi, Scott North, Luis Chu, Kim N., Robert J. Jones, Oscar B. Goodman, Fred Saad, John Staffurth, Paul N. Mainwaring, Stephen Harland, Thomas W. Flaig, Thomas E. Hutson, Tina Cheng, Helen Patterson, John D. Hainsworth, Charles J. Ryan, Cora N. Sternberg, Susan Ellard, Aude Fléchon, Mansoor N. Saleh, Mark C. Scholz, Eleni Efstathiou, Andrea Zivi, Diletta Bianchini, Yohann Loriot, Nicole Chieffo, Thian Kheoh, Christopher M. Haqq, Howard I. Scher
New England Journal of Medicine. 20114,422 CitationsOPEN ACCESS
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Charles J. Ryan, Matthew R. Smith, Johann S. de Bono, Arturo Molina, Christopher J. Logothetis, Paul de Souza, Karim Fizazi, Paul N. Mainwaring, Josep M. Piulats, Siobhan Ng, Joan Carles, Peter F.A. Mulders, Ethan Basch, Eric J. Small, Fred Saad, Dirk Schrijvers, Hendrik Van Poppel, Som D. Mukherjee, H. Suttmann, Winald R. Gerritsen, Thomas W. Flaig, Daniel J. George, Evan Y. Yu, Eleni Efstathiou, Allan J. Pantuck, Eric Winquist, Celestia S. Higano, Mary-Ellen Taplin, Youn Park, Thian Kheoh, Thomas W. Griffin, Howard I. Scher, Dana E. Rathkopf
New England Journal of Medicine. 20122,811 CitationsOPEN ACCESS
Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology
Thomas W. Flaig, Philippe E. Spiess, Michael Abern, Rick Bangs, Rick Bangs, Jovan Begovic, Jason Brown, Mark K. Buyyounouski, Kevin Chan, Paul Chang, Arnold I. Chin, Khurshid A. Guru, Harry W. Herr, Jean Hoffman‐Censits, Hristos Kaimakliotis, Shilajit Kundu, Subodh M. Lele, Amy Luckenbaugh, Jonathan Maldonado, Lin Mei, Jeffrey S. Montgomery, Mamta Parikh, Anthony Patterson, Charles Peyton, Elizabeth R. Plimack, Mark A. Preston, Kyle Richards, Steven Seyedin, Arlene O. Siefker‐Radtke, Tyler Stewart, Debasish Sundi, Umang Swami, Matthew Tollefson, Jonathan L. Wright, Carly J. Cassara, Bailee Sliker
Journal of the National Comprehensive Cancer Network. 2020634 CitationsOPEN ACCESS
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
Thomas Powles, Michiel S. van der Heijden, Daniel Castellano, Matthew D. Galsky, Yohann Loriot, Daniel P. Petrylak, Osamu Ogawa, Se Hoon Park, Jae‐Lyun Lee, Ugo De Giorgi, Martin Bögemann, Aristotelis Bamias, Bernhard J. Eigl, Howard Gurney, Som D. Mukherjee, Yves Fradet, Iwona Skoneczna, Marinos Tsiatas, Andrey Novikov, Cristina Suárez, André P. Fay, Ignacio Durán, Andrea Necchi, Sophie Wildsmith, Philip He, Natasha Angra, Ashok Gupta, Wendy J. Levin, Joaquim Bellmunt, Se Hoon Park, Michiel S. van der Heijden, Andrea Necchi, Daniel Castellano, Aristotelis Bamias, Jae‐Lyun Lee, Ugo De Giorgi, Martin Bögemann, Bernhard J. Eigl, Marinos Tsiatas, Thomas Powles, Andrey Novikov, Iwona Skoneczna, Som D. Mukherjee, Cristina Suárez, Hans M. Westgeest, Yves Fradet, Aude Fléchon, Yen‐Chuan Ou, Inkeun Park, Vsevolod Matveev, Begoña Pérez‐Valderrama, Susanna Cheng, Stephen Jay Frank, Howard Gurney, Urbano Anido, Alketa Hamzaj, Margitta Retz, Srikala S. Sridhar, Giorgio V. Scagliotti, Jens Voortman, B. Yа. Alekseev, Anna Alyasova, B. K. Komyakov, Herlinde Dumez, Michel Pavic, Go Kimura, Atsushi Mizokami, Susanne Osanto, José Ángel Arranz, Djura Piersma, Sang Joon Shin, O. B. Karyakin, Ignacio Delgado, José Luis González, See‐Tong Pang, Anna Tran, Oleg Lipatov, Wen-Pin Su, Thomas W. Flaig, Ajjai Alva, Hwa Park Kyong, Evgeny Kopyltsov, Elena Almagro, M. Doménech, Yen‐Hwa Chang, Brieuc Sautois, Andre Ravaux, Gerasimos Aravantinos, V. Georgoulias, Sasja F. Mulder, Yu Jung Kim, Fabio Kater, Christine Chevreau, Scott T. Tagawa, Paweł Zalewski, Florence Joly, Yohann Loriot, Gencay Hatiboglu, Luca Gianni, Franco Morelli
The Lancet Oncology. 2020502 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account